Nonulcer Dyspepsia | The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia
Nonulcer Dyspepsia research study
What is the primary objective of this study?
The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI)
treatment in patients with functional dyspepsia.
Who is eligible to participate?
- aged 18-45 years with symptoms of dyspepsia,
- no evidence of organic disease.
- Patients with alarm symptoms,
- Severe concomitant illness,
- Pregnancy or lactation,
- Alcohol or drug abuse,
- Use of aspirin or other non-steroidal anti-inflammatory drugs antibiotics, H2 receptor
blockers, bismuth, or proton pump inhibitors in the preceding two weeks
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Drug:Pantoprazol40mg/day, oral, 28 days
Drug:Folic Acid5 mg/day, oral, 28 days
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: June 2012
Completed Date: June 2013
Phase: Phase 4
Primary Outcome: Effectiveness of pantoprazole treatment in patients with functional dyspepsia measured by symptoms scale.
Study sponsors, principal investigator, and references
Lead Sponsor: Bezmialem Vakif University